Canopy Biosciences

About

Canopy Biosciences is a life science company based in the Cortex Innovation District of St. Louis, Missouri. Founded in 2016 by experts in biomedical research and genetic engineering, the company focuses on advancing life science reagent tools and services through in-licensing. Canopy Biosciences became part of Bruker on September 11, 2020. The company offers research tools for targeted genome editing, molecular biology, and personalized medicine. It collaborates with researchers to develop their discoveries into market-ready products. Canopy Biosciences' technologies are included in Bruker Spatial Biology's portfolio, which features solutions for spatial biology research, such as the CosMx Spatial Molecular Imager and the GeoMx Digital Spatial Profiler. The company has also secured funding and filed patents related to cell biology and imaging technologies.